Head and Neck Cancer
A phase 3 open-label, randomized, controlled study to evaluate the efficacy and safety of petosemtamab compared with investigator's choice monotherapy treatment in previously treated patients with incurable, metastatic/recurrent head and neck squamous cell carcinoma (MCLA-158-CL02)
- Details
ClinicalTrials.gov ID:
NCT06496178
Diagnosis Type:
NA
USOR Number:
- Address
,
P: